Persistent URL of this record https://hdl.handle.net/1887/3565045
Documents
-
- Download
- Full text
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Tepotinib efficacy and safety in patients with MET exon 14 skipping NSCLC: outcomes in patient subgroups from the VISION study with relevance for clinical practice
- All authors
- X.N. le; Sakai, H.; Felip, E.; Veillon, R.; Garassino, M.C.; Raskin, J.; Cortot, A.B.; Viteri, S.; Mazieres, J.; Smit, E.F.; Thomas, M.; Iams, W.T.; Cho, B.C.; Kim, H.R.; Yang, J.C.H.; Chen, Y.M.; Patel, J.D.; Bestvina, C.M.; Park, K.; Griesinger, F.; Johnson, M.; Gottfried, M.; Britschgi, C.; Heymach, J.; Sikoglu, E.; Berghoff, K.; Schumacher, K.M.; Bruns, R.; Otto, G.; Paik, P.K.
- Date
- 2022-03-15
- Journal
- Clinical Cancer Research
- Volume
- 28
- Issue
- 6
- Pages
- 1117 - 1126